GlassScriptPhysician profile
Michael J Samalik
NPI 1508832098
$1,437.40
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $690 · 2020: $748.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $318.68 | 2019-2020 | |
| Pfizer INC. | $179.25 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.85 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $147.50 | 2019-2020 | |
| Amarin Pharma, INC. | $114.97 | 2020 | |
| Novo Nordisk INC | $101.83 | 2019-2020 | |
| Glaxosmithkline, LLC. | $47.53 | 2019-2020 | |
| Allergan, INC. | $45.19 | 2020 | |
| Sunovion Pharmaceuticals INC. | $44.45 | 2019-2020 | |
| Lilly USA, LLC | $38.52 | 2020 | |
| Amgen INC. | $33.18 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $31.79 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $29.19 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $28.55 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $24.10 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $19.48 | 2020 | |
| Resmed Corp | $18.36 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $16.95 | 2020 | |
| Horizon Therapeutics Plc | $15.28 | 2019 | |
| Esperion Therapeutics, INC. | $14.92 | 2020 | |
| Bioventus LLC | $13.83 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Samalik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.